1-7 of 7
Francine M. Foss
Close
Sort by
Journal Articles

Phase 2 Trial of the Farnesyltransferase Inhibitor Tipifarnib for Relapsed/Refractory Peripheral T Cell Lymphoma

Clinical Trials & Observations
Thomas E. Witzig, Lubomir Sokol, Won Seog Kim, Fátima de la Cruz, Alejandro Martin Martin Garcia-Sancho, Ranjana H Advani, Josep Maria Roncero Vidal, Raquel De Oña, Ana Marin-Niebla, Antonia Rodriguez Izquierdo, Maria José Terol, MD, Eva Domingo-Domenech, Andrew Saunders, Nawal Bendris, Julie Mackey, Mollie Leoni, Francine M Foss
Journal: Blood Advances
Blood Adv bloodadvances.2024012806.
https://doi.org/10.1182/bloodadvances.2024012806
Published: 2024
Includes: Supplemental data
Journal Articles

The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network

Greg Hapgood, Monica Civallero, Yana Stepanishyna, Julie Vose, Monica Elena Cabrera, Ranjana H. Advani, Stefano A. Pileri, Martina Manni, Steven M. Horwitz, Francine M. Foss, Felicitas Hitz, John Radford, Ivan Dlouhy, Carlos Chiattone, Won Seog Kim, Tetiana Skrypets, Arnon Nagler, Judith Trotman, Stefano Luminari, Massimo Federico
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5047–5054.
https://doi.org/10.1182/bloodadvances.2023010037
Published: 2023
Includes: Supplemental data
Journal Articles

Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma

Kunal C. Potnis, Mengyang Di, Iris Isufi, Lohith Gowda, Stuart E. Seropian, Francine M. Foss, Howard P. Forman, Scott F. Huntington
Journal: Blood Advances
Blood Adv (2023) 7 (5): 801–810.
https://doi.org/10.1182/bloodadvances.2022008097
Published: 2023
Includes: Supplemental data
Journal Articles

Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populations

Jingjing Ren, Rihao Qu, Nur-Taz Rahman, Julia M. Lewis, Amber Loren Ong King, Xiaofeng Liao, Fatima N. Mirza, Kacie R. Carlson, Yaqing Huang, Scott Gigante, Benjamin Evans, Barani Kumar Rajendran, Suzanne Xu, Guilin Wang, Francine M. Foss, William Damsky, Yuval Kluger, Smita Krishnaswamy, Michael Girardi
Journal: Blood Advances
Blood Adv (2023) 7 (3): 445–457.
https://doi.org/10.1182/bloodadvances.2022008168
Published: 2023
Includes: Supplemental data
Journal Articles

Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis

Nazila Shafagati, Min J. Koh, Leora Boussi, Hyun J. Park, Robert Stuver, Paul Bain, Francine M. Foss, Changyu Shen, Salvia Jain
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4740–4762.
https://doi.org/10.1182/bloodadvances.2022007425
Published: 2022
Includes: Supplemental data
Journal Articles

Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas

Min Jung Koh, Mwanasha H. Merrill, Min Ji Koh, Robert Stuver, Carolyn D. Alonso, Francine M. Foss, Angel M. Mayor, John Gill, Marta Epeldegui, Edward Cachay, Jennifer E. Thorne, Michael J. Silverberg, Michael A. Horberg, Keri N. Althoff, Ank E. Nijhawan, Kathleen A. McGinnis, Jennifer S. Lee, Charles S. Rabkin, Sonia Napravnik, Jun Li, Jessica L. Castilho, Changyu Shen, Salvia Jain
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1420–1431.
https://doi.org/10.1182/bloodadvances.2021006208
Published: 2022
Includes: Supplemental data
Journal Articles

JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCL

Sara Yumeen, Fatima N. Mirza, Julia M. Lewis, Amber Loren O. King, Sa Rang Kim, Kacie R. Carlson, Sheila R. Umlauf, Yulia V. Surovtseva, Francine M. Foss, Michael Girardi
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2213–2226.
https://doi.org/10.1182/bloodadvances.2020001756
Published: 2020
Includes: Supplemental data